KYMR

Kymera Therapeutics, Inc. Healthcare - Biotechnology Investor Relations →

NO
122.9% ABOVE
↑ Moving away Was 104.8% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $35.71
14-Week RSI 62

Kymera Therapeutics, Inc. (KYMR) closed at $79.59 as of 2026-02-02, trading 122.9% above its 200-week moving average of $35.71. The stock moved further from the line this week, up from 104.8% last week. The 14-week RSI sits at 62, indicating neutral momentum.

Over the past 237 weeks of data, KYMR has crossed below its 200-week moving average 4 times. On average, these episodes lasted 34 weeks. The average one-year return after crossing below was -22.9%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $6.4 billion, KYMR is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -32.1%. The stock trades at 6.0x book value.

Share count has increased 25.9% over three years, indicating dilution.

Over the past 4.7 years, a hypothetical investment of $100 in KYMR would have grown to $132, compared to $168 for the S&P 500. KYMR has returned 6.2% annualized vs 11.7% for the index, underperforming the broader market over this period.

In the past 12 months, corporate insiders have made 3 open-market purchases totaling $215,297,266.

Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: KYMR vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After KYMR Crosses Below the Line?

Across 4 historical episodes, buying KYMR when it crossed below its 200-week moving average produced an average return of +33.5% after 12 months (median -6.0%), compared to +8.8% for the S&P 500 over the same periods. 25% of those episodes were profitable after one year. After 24 months, the average return was -17.0% vs +11.0% for the index.

Each line shows $100 invested at the moment KYMR crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Insider Buying Activity

3 conviction buys in the past 12 months (purchases over $500K with meaningful position increases).

DateInsiderTitleValueSharesPosition +%
2025-12-11BAKER BROS ADVISORS L.P.Beneficial Owner of more than 10% of a Class of Security$172,499,9182,005,813+30.2%
2025-06-30BVF PARTNERS L PAffiliated Person$13,955,348317,167+6.3%
2025-06-30BAKER BROS ADVISORS L.P.Director$28,842,000655,500+8.2%

Historical Touches

KYMR has crossed below its 200-week MA 4 times with an average 1-year return of +-22.9% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jan 2022Feb 202410871.3%-15.9%+93.8%
Apr 2024Apr 2024410.4%-39.4%+118.7%
May 2024Jul 2024819.6%-13.4%+127.7%
Feb 2025Jun 20251437.8%N/A+153.9%
Average34+-22.9%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02